Ad
related to: lancet author statement form printable
Search results
Results From The WOW.Com Content Network
Author: Himsworth HP Publication data: Lancet 1936;i:127-130. Online version: Description: Himsworth noted that there are two main types of diabetes, the insulin-depleted (type 1) and the insulin-resistant form (type 2). Insulin resistance is a term and concept of his coinage. Importance: Breakthrough, Impact
It also invited Daszak and other authors of the letter to amend their competing interest statements. Daszak amended his statement to describe the research he has done in southeast Asia, with various different institutions including the Wuhan Institute of Virology. Daszak also recused himself from The Lancet's COVID-19 origins inquiry. [23] [24 ...
The Lancet was criticised after it published a paper in 1998 in which the authors suggested a link between the MMR vaccine and autism spectrum disorder. [44] In February 2004, The Lancet published a statement by 10 of the paper's 13 coauthors repudiating the possibility that MMR could cause autism. [45]
The STROBE Statement was developed by the STROBE Initiative, an international collaboration of epidemiologists, methodologists, statisticians, researchers and journal editors with the aim to assist authors when writing up analytical observational studies, to support editors and reviewers when considering such articles for publication, and to help readers when critically appraising published ...
The aim of the PRISMA statement is to help authors improve the reporting of systematic reviews and meta-analyses. [3] PRISMA has mainly focused on systematic reviews and meta-analysis of randomized trials, but it can also be used as a basis for reporting reviews of other types of research (e.g., diagnostic studies, observational studies).
The Lancet Digital Health is an open-access, peer-reviewed monthly journal dedicated to the rapidly evolving field of digital health. The journal addresses the intersection of technology and health, focusing on how digital tools can inform and improve clinical practices and outcomes worldwide.
eBioMedicine is a peer-reviewed open access medical journal initially launched by Elsevier, shortly thereafter supported by Cell Press and The Lancet, and in 2018 incorporated in The Lancet family journals, at the occasion of the inception of its sister journal eClinicalMedicine (Impact Factor 9.6), also published by The Lancet. [1]
the authors disclose the existence of the preprint at submission (e.g. in the cover letter) once an article is published, the preprint should link to the published version (typically via DOI ) the preprint should not have been formally peer reviewed